---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-067209"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:32:57.907372+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Denali Capital extends business combination deadline to Sep 11 via $180K Scilex note

## Summary
- Deposited $15,036.74 into trust to extend deadline to Sep 11, 2024 from Aug 11.
- Issued up to $180,000 convertible note to Scilex (SCLX); initial draw $15,036.74.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10/share.
- Remaining $164,963.26 available for future monthly extensions as needed.
- If no business combination, note repaid only from non-trust funds or forfeited.

## SEC filing metadata
- accession: 0001213900-24-067209
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390024067209/0001213900-24-067209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024067209/ea0211006-8k425_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-067209
- JSON: https://secwatch.observer/filing/0001213900-24-067209.json
- Plain text: https://secwatch.observer/filing/0001213900-24-067209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.